Anzeige
❌
Mehr »
Dienstag, 17.11.2026 - Börsentäglich über 12.000 News
Milliardenmarkt Quantensicherheit! Ist diese Aktie noch völlig unterschätzt?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DNC4 | ISIN: CA4838092084 | Ticker: N/A
1-Jahres-Chart
KANE BIOTECH INC Chart 1 Jahr
5-Tage-Chart
KANE BIOTECH INC 5-Tage-Chart

Aktuelle News zur KANE BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.11.Kane Biotech Inc (2): Kane publishes clinical study in Int'l Wound Journal1
KANE BIOTECH Aktie jetzt für 0€ handeln
04.11.Kane Biotech Inc.: Kane Announces Publication of Real-World Evidence in the International Wound Journal3
22.10.Kane Biotech Inc (2): Kane Biotech hires ITG for market-making services2
21.10.Kane Biotech Inc.: Kane Engages Independent Trading Group as Market Maker1
20.10.Kane Biotech Inc (2): Kane Biotech signs Stevens as Canadian distributor1
20.10.Kane Biotech signs distribution deal with Stevens Company1
20.10.Kane Biotech Inc.: Kane Biotech Signs Distribution Agreement with The Stevens Company4
19.10.Kane Biotech Inc.: Kane Launches New Corporate Brand and Redesigned Website1
16.10.Kane Biotech Inc (2): Kane Biotech gets insider loan to keep the lights on1
16.10.Kane Biotech Inc.: Kane Biotech Announces $250,000 Insider Loan1
07.10.Kane Biotech Inc.: Kane Biotech to Present Clinical Data and Showcase revyve Product Line at SAWC Fall 20262
09.09.Kane Biotech Inc (2): Kane Biotech to host commercial update webcast Sept. 161
09.09.Kane Biotech Inc.: Kane Biotech to Host Commercial Update Webcast on September 161
02.09.Kane Biotech Inc.: Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.204WINNIPEG, Manitoba, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the "Company", "Kane" or "Kane Biotech") is pleased to announce that it has entered into a non-exclusive distribution...
► Artikel lesen
27.08.Kane Biotech Inc.: Kane Biotech Announces Second Quarter 2026 Financial Results426WINNIPEG, Manitoba, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the "Company", "Kane" or "Kane Biotech") announces today its second quarter 2026 financial results. Second Quarter...
► Artikel lesen
05.08.Kane Biotech Inc (2): Kane Biotech hires DNA Advisors as financial adviser1
05.08.Kane Biotech Inc.: Kane Biotech Announces Engagement of DNA Advisors389WINNIPEG, Manitoba, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE) ("Kane" or the "Company"), announces that it has retained DNA Advisors Inc. ("DNA Advisors") as its exclusive financial...
► Artikel lesen
02.07.Kane Biotech Inc (2): Kane Biotech shareholders approve matters at meeting1
02.07.Kane Biotech Inc.: Kane Biotech Announces Results of Annual and Special Meeting of Shareholders275WINNIPEG, Manitoba, July 02, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the "Company", "Kane" or "Kane Biotech") the voting results from its annual and special meeting of shareholders...
► Artikel lesen
30.05.Kane Biotech Inc (2): Kane Biotech grants options to buy 9.75 million shares5
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1